Trials / Completed

CompletedNCT00002074

Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Maintenance Treatment for the Prevention of Relapse of Cryptococcal Meningitis in Patients With Acquired Immunodeficiency Syndrome

Status: Completed
Phase: N/A
Study type: Interventional
Enrollment: —

Sponsor: Pfizer · Industry
Sex: All
Age: 18 Years
Healthy volunteers: Not accepted

Summary

To compare the safety and effectiveness of fluconazole and amphotericin B as maintenance treatment for preventing the relapse of cryptococcal meningitis in patients with AIDS.

Conditions

Meningitis, Cryptococcal
HIV Infections

Interventions

Type	Name	Description
DRUG	Fluconazole
DRUG	Amphotericin B

Timeline

First posted: 2001-08-31
Last updated: 2005-06-24

Locations

39 sites across 2 countries: United States, Canada

Source: ClinicalTrials.gov record NCT00002074. Inclusion in this directory is not an endorsement.